资源描述：
《《肺癌治疗新突破》ppt课件》由会员上传分享，免费在线阅读，更多相关内容在教育资源-天天文库。
1、2008肺癌治疗新突破上海交通大学附属上海市胸科医院上海市肺部肿瘤临床医学中心陆舜2008年美国预计因癌症致死的人数*ONS=Othernervoussystem.Source:AmericanCancerSociety,2008.Men 294,120Women 271,53026%Lung&bronchus15%Breast9%Colon&rectum6%Pancreas6%Ovary3%Non-Hodgkin lymphoma3%Leukemia3%Uterinecorpus2%Liver&intrahepaticbileduct2%Brain/ONS25%Allothersit
2、esLung&bronchus31%Prostate10%Colon&rectum8%Pancreas6%Liver&intrahepatic4% bileductLeukemia4%Esophagus4%Urinarybladder3%Non-Hodgkin3%lymphomaKidney&renalpelvis3%Allothersites24%男性中癌症死亡*,美国,1930-2004*Age-adjustedtothe2000USstandardpopulation.Source:USMortalityData1960-2004,USMortalityVolumes1930-1
3、959,NationalCenterforHealthStatistics,CentersforDiseaseControlandPrevention,2006.肺与支气管结直肠胃RatePer100,000前列腺胰腺肝脏白血病*Age-adjustedtothe2000USstandardpopulation.Source:USMortalityData1960-2004,USMortalityVolumes1930-1959,NationalCenterforHealthStatistics,CentersforDiseaseControlandPrevention,2006.肺与
4、支气管结直肠子宫胃乳腺卵巢胰腺RatePer100,000女性中癌症死亡*,美国,1930-20046各部位癌症发生率(男性,美国,1999-2001)Source:DevCan:ProbabilityofDevelopingorDyingofCancerSoftware,Version5.2StatisticalResearchandApplicationsBranch,NCI,2004.http://srab.cancer.gov/devcan部位发生率所有部位1/2前列腺1/2肺与支气管1/13结直肠1/17泌尿膀胱1/28非霍奇金淋巴瘤1/46黑素瘤1/53肾1/67白血病1/
5、68口腔1/73胃1/817Source:DevCan:ProbabilityofDevelopingorDyingofCancerSoftware,Version5.2StatisticalResearchandApplicationsBranch,NCI,2004.http://srab.cancer.gov/devcan部位发生率所有部位1/3乳腺1/7肺与支气管1/18结直肠1/18子宫体1/38非霍奇金淋巴瘤1/56卵巢1/68黑色素瘤1/78胰腺1/81膀胱1/88子宫颈1/130各部位癌症发生率(女性,美国,1999-2001)83个时间段 发生癌症部位相对生存率*(%)
6、*5-yearrelativesurvivalratesbasedonfollowupofpatientsthrough2001.†Recentchangesinclassificationofovariancancerhaveaffected1995-2000survivalratesSource:Surveillance,Epidemiology,andEndResultsProgram,1975-2001,DivisionofCancerControlandPopulationSciences,NationalCancerInstitute,2004.部位1974-1976198
7、3-19851995-2000所有部位505364乳腺(女性)757888结肠505863白血病344146肺与支气管131415皮肤黑色素瘤808591非霍奇金淋巴瘤475459卵巢374144†胰腺334前列腺677599直肠495564膀胱737882可手术NSCLC的术后辅助化疗NSCLC的新辅助化疗局部晚期NSCLC的治疗晚期NSCLC一线治疗NSCLC维持治疗NSCLC的生物标记物NSCLC的新分期顺铂为基础的辅助化疗用于可切除的非
